Please login to the form below

Not currently logged in
Email:
Password:

cerebral adrenoleukodystrophy

This page shows the latest cerebral adrenoleukodystrophy news and features for those working in and with pharma, biotech and healthcare.

EU approves bluebird bio’s CALD gene therapy Skysona

EU approves bluebird bio’s CALD gene therapy Skysona

The European Commission (EC) has approved bluebird bio’s gene therapy Skysona for the rare inherited neurological disease cerebral adrenoleukodystrophy (CALD). ... Once this functional gene is added to a CALD patient’s stem cells, the patient's body

Latest news

More from news
Approximately 0 fully matching, plus 8 partially matching documents found.

Latest Intelligence

More from intelligence
Approximately 0 fully matching, plus 2 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Syneos Health®

Syneos Health® (Nasdaq:SYNH) is the only fully integrated biopharmaceutical solutions organization. The Company, including a Contract Research Organization (CRO) and...

Latest intelligence

Health literacy in the time of COVID-19
In a time when much of the media’s focus is on the ongoing COVID-19 pandemic and the differences in vaccination rates between various regions, countries, and socioeconomic groups, improving health...
Rare thoughts & outcomes - navigating pathways to better outcomes in rare
...
How to pick the perfect training program for your healthcare professionals
You know your team needs training. But not all training providers and programs are created equal. Last week, we shared the benefits of working with specialist learning and development (L&D)...